[HTML][HTML] Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating …
J Liu, L Lai, J Lin, J Zheng, X Nie, X Zhu… - International journal of …, 2020 - ncbi.nlm.nih.gov
Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
[引用][C] Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating …
F Lindemann, S Oebel, I Paetsch, A Arya… - International Journal of …, 2020 - hero.epa.gov
Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and
mitigates its cardiovascular and renal damage through modulating gut microbiota | Health & …
mitigates its cardiovascular and renal damage through modulating gut microbiota | Health & …
[HTML][HTML] Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating …
J Liu, L Lai, J Lin, J Zheng, X Nie, X Zhu, J Xue… - International Journal of …, 2020 - ijbs.com
Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut …
J Liu, L Lai, J Lin, J Zheng, X Nie, X Zhu… - International Journal of …, 2020 - europepmc.org
Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
[PDF][PDF] Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating …
J Liu, L Lai, J Lin, J Zheng, X Nie… - International …, 2020 - pdfs.semanticscholar.org
Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut …
J Liu, L Lai, J Lin, J Zheng, X Nie… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Trimethylamine N-oxide (TMAO) leads to the development of cardiovascular and chronic
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …
kidney diseases, but there are currently no potent drugs that inhibit the production or toxicity …